|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2100051134 |
|
最近更新日期: Date of Last Refreshed on: |
2021-09-14 22:29:41 |
|
注册时间: Date of Registration: |
2021-09-14 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
不同方式的疝囊处理对腹腔镜经腹腔腹股沟疝修补术(TAPP)术后并发症的影响:一项前瞻性、随机、对照研究 |
|
Public title: |
A prospectively randomized control study to assess the outcome of different procedures in TAPP hernia sac disposition |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同方式的疝囊处理对腹腔镜经腹腔腹股沟疝修补术(TAPP)术后并发症的影响:一项前瞻性、随机、对照研究 |
|
Scientific title: |
A prospectively randomized control study to assess the outcome of different procedures in TAPP hernia sac disposition |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
施晗 |
研究负责人: |
黄鹤光 |
|
Applicant: |
Shi Han |
Study leader: |
Huang Heguang |
|
申请注册联系人电话: Applicant telephone: |
18558836165 |
研究负责人电话: Study leader's telephone: |
13705947538 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
2213517953@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
heguanghuang123@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
福建医科大学附属协和医院 |
研究负责人通讯地址: |
福建医科大学附属协和医院 |
|
Applicant address: |
Fujian Medical University Union Hospital |
Study leader's address: |
Fujian Medical University Union Hospital |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
福建医科大学附属协和医院 |
||
|
Applicant's institution: |
Fujian Medical University Union Hospital |
||
|
研究负责人所在单位: |
|
||
|
Affiliation of the Leader: |
|
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2018YF013-02 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
福建医科大学附属协和医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Fujian Medical University Union Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2018-08-30 00:00:00 |
||
|
伦理委员会联系人: |
陈良万 |
||
|
Contact Name of the ethic committee: |
Chen Liangwang |
||
|
伦理委员会联系地址: |
福建省福州市鼓楼区新权路29号 |
||
|
Contact Address of the ethic committee: |
No. 29, Xinquan Road, Gulou District, Fuzhou City, Fujian Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
福建医科大学附属协和医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Fujian Medical University Union Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
福建省福州市鼓楼区新权路29号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 29, Xinquan Road, Gulou District, Fuzhou City, Fujian Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
福建省微创技术医疗中心 |
||||||||||||||||||||||
|
Source(s) of funding: |
Medical Center of Minimally |
||||||||||||||||||||||
|
Target disease: |
Indirect inguinal hernia |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
与传统经腹腔腹膜前修补术相比较,探讨改良TAPP术式(将疝囊横断后远端疝囊缝合固定至腹直肌后技术)对患者术后并发症的发生,术后住院时间、医疗费用及生活质量的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
Compared with the traditional transperitoneal preperitoneal repair, to explore the effects of the improved TAPP operation (the technique of suture and fixation of the distal hernia sac after the transection of the hernia sac to the rectus abdominis) on the occurrence of postoperative complications, postoperative hospital stay, medical expenses and quality of life. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
(1)年龄18-85岁;(2)查体或是腹股沟彩超证实为腹股沟疝患者;(3)术中证实腹股沟疝为斜疝,且Gilbert分型(1988)为II型或III型者(疝环缺损不小于一指),且术中证实疝囊长度大于3厘米;(4)具备足够的器官功能;(5)病人或家属,能够理解研究方案并愿意参与本研究,提供书面知情同意。 |
||||||||||||||||||||||
|
Inclusion criteria |
(1) Age 18-85 years(2) Patients with inguinal hernia confirmed by physical examination or inguinal color Doppler ultrasound(3) The inguinal hernia was confirmed as indirect hernia during operation, and the Gilbert classification (1988) was type II or type III (the hernia ring defect was not less than one finger), and the length of hernia sac was confirmed to be greater than 3cm during operation(4) Adequate organ function(5) Patients or family members who can understand the study protocol and are willing to participate in the study and provide written informed consent. |
||||||||||||||||||||||
|
排除标准: |
(1)年龄<18,或>85岁;(2)复发疝、嵌顿疝和绞窄疝的患者;(3)合并肠梗阻、肠穿孔、肠出血等需要急诊手术切除的患者;(4)ASA IV或V级;(5)严重的精神疾病;(6)严重肺气肿、间质性肺炎或缺血性心脏病等不能耐受手术者;(7)患者具有腹腔镜手术禁忌;(8)患者或家属无法理解本研究的条件和目标。 |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Age < 18, or > 85 years(2) Patients with recurrent hernia, incarcerated hernia and strangulated hernia(3) Patients with intestinal obstruction, intestinal perforation and intestinal bleeding requiring emergency surgical resection(4) ASA class IV or V(5) Serious mental illness(6) Patients with severe emphysema, interstitial pneumonia or ischemic heart disease who cannot tolerate surgery(7) Patients had contraindications to laparoscopic surgery(8) Patients or family members cannot understand the conditions and objectives of this study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2018-09-01 00:00:00至 To 2021-01-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2018-09-01 00:00:00 至 To 2021-04-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究采用简单随机分组,在计算机上利用统计软件产生随机数字表。采用密闭不透光信封进行随机隐藏。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
In this study, a simple random grouping was used to generate a random number table by using statistical software on the computer. A sealed opaque envelope is used for random hiding. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
ResMan 临床试验公共管理平台, http://www.medresman.org.cn |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan, http://www.medresman.org.cn. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集和管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic data caoture |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |